Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.38 USD
83.59 M USD
1.98 B USD
214.41 M
About Qiagen N.V.
Sector
Industry
CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0015002CX3
FIGI
BBG000GTYWL7
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Qiagen NV 🧙Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the bal
QGEN (Qiagen N.V) - Bullish quarterly outlookQiagen N.V
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Based on the stu
The Perception of QIAGEN DailyHello traders, QIAGEN is in a bullish push with sellers rejecting a buy candle and low bull volume. On the TIMEFRAME 30 15 Min a bull hammer move and in the 5 1 Min is in bullish continuity. Great likelihood of starting on the next high which corresponds to the middle of the median. And if the buyer
Great Look for QGENLoving this setup. QGEN has struggled with this level for over a year. Recently it has consolidated with very tight price action and low volume at the highs. Volume has started to come in over the last two days as it looks to make a run for it. A good swing trade candidate. A move below $41 would ha
Shot in the darkThis stock has a ton of positive hype surrounding it because of the 'rona. Nonetheless, the chart screams institutional liquidation to me. This is a gut feeling and I could easily be wrong a hundred fold. Something doesn't fit right and makes me I'm painting a picture in my head where institutional
QIAGEN NV (QGEN) - GAP-FILL TRADEEntry Point: When price crosses above 50 DMA (blue line). This allows prices to take over 50 Week MA and 20 Month MA first.
Profit Taking: Around $40.50 when gap about to close
Stop Loss: When price crosses below 20 DMA to minimize heavy loss. For me, I will exit when price crosses below the support
Qiagen NV Bullish perspective Coronavirus Stock $qgenQGEN announced the shipping of its latest QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation purposes. The latest test kit helps detect the novel coronavirus SARS-CoV-2, thus adding rapid Sample to Insight syndromic testing to the company’s molecular testing so
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
A3L06J
QIAGEN 24/31 CVYield to maturity
2.81%
Maturity date
Sep 10, 2031
QGEN5328376
QIAGEN N.V. 0.0% 17-DEC-2027Yield to maturity
1.74%
Maturity date
Dec 17, 2027
See all QGEN bonds
Related stocks
Frequently Asked Questions
The current price of QGEN is 40.71 USD — it has decreased by −1.25% in the past 24 hours. Watch Qiagen N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Qiagen N.V. stocks are traded under the ticker QGEN.
QGEN stock has risen by 2.12% compared to the previous week, the month change is a 2.76% rise, over the last year Qiagen N.V. has showed a 0.099% increase.
We've gathered analysts' opinions on Qiagen N.V. future price: according to them, QGEN price has a max estimate of 55.00 USD and a min estimate of 43.00 USD. Watch QGEN chart and read a more detailed Qiagen N.V. stock forecast: see what analysts think of Qiagen N.V. and suggest that you do with its stocks.
QGEN reached its all-time high on Jul 17, 2000 with the price of 64.42 USD, and its all-time low was 1.93 USD and was reached on Jul 16, 1996. View more price dynamics on QGEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
QGEN stock is 3.60% volatile and has beta coefficient of 0.56. Track Qiagen N.V. stock price on the chart and check out the list of the most volatile stocks — is Qiagen N.V. there?
Today Qiagen N.V. has the market capitalization of 8.96 B, it has increased by 0.24% over the last week.
Yes, you can track Qiagen N.V. financials in yearly and quarterly reports right on TradingView.
Qiagen N.V. is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
QGEN earnings for the last quarter are 0.61 USD per share, whereas the estimation was 0.62 USD resulting in a −1.02% surprise. The estimated earnings for the next quarter are 0.50 USD per share. See more details about Qiagen N.V. earnings.
Qiagen N.V. revenue for the last quarter amounts to 521.00 M USD, despite the estimated figure of 521.05 M USD. In the next quarter, revenue is expected to reach 468.87 M USD.
QGEN net income for the last quarter is 88.32 M USD, while the quarter before that showed 98.06 M USD of net income which accounts for −9.93% change. Track more Qiagen N.V. financial stats to get the full picture.
Qiagen N.V. dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 18, 2025, the company has 5.76 K employees. See our rating of the largest employees — is Qiagen N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Qiagen N.V. EBITDA is 698.23 M USD, and current EBITDA margin is 35.30%. See more stats in Qiagen N.V. financial statements.
Like other stocks, QGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Qiagen N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Qiagen N.V. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Qiagen N.V. stock shows the sell signal. See more of Qiagen N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.